The ursodeoxycholic acid story in primary biliary cirrhosis.
作者信息
Lim A G, Jazrawi R P, Northfield T C
机构信息
Division of Biochemical Medicine, St George's Hospital Medical School, London.
出版信息
Gut. 1995 Sep;37(3):301-4. doi: 10.1136/gut.37.3.301.
Abstract
摘要
相似文献
1
The ursodeoxycholic acid story in primary biliary cirrhosis.
Gut. 1995 Sep;37(3):301-4. doi: 10.1136/gut.37.3.301.
2
[Primary biliary cirrhosis and ursodeoxycholic acid therapy].
Nihon Naika Gakkai Zasshi. 1996 Mar 10;85(3):399-403.
3
Ursodeoxycholic acid for primary biliary cirrhosis: lessons from the past--issues for the future.
J Hepatol. 2000 Apr;32(4):685-8. doi: 10.1016/s0168-8278(00)80232-9.
4
Ursodeoxycholic acid for primary biliary cirrhosis.
Drug Ther Bull. 1999 Apr;37(4):30-2. doi: 10.1136/dtb.1999.37430.
5
Patients and patience: the pitfalls of primary biliary cirrhosis trials.
Nat Clin Pract Gastroenterol Hepatol. 2005 Dec;2(12):552-3. doi: 10.1038/ncpgasthep0360.
6
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis.
Clin Res Hepatol Gastroenterol. 2011 Jan;35(1):29-33. doi: 10.1016/j.gcb.2010.07.018.
7
Ursodeoxycholic acid for primary biliary cirrhosis.
Cochrane Database Syst Rev. 2002(1):CD000551. doi: 10.1002/14651858.CD000551.
8
[Medical treatment of chronic cholestasis: ursodeoxycholic acid].
Gastroenterol Hepatol. 2000 Feb;23 Suppl 1:24-38.
9
Ursodeoxycholic acid for primary biliary cirrhosis.
Lancet. 2000 Feb 19;355(9204):657-8. doi: 10.1016/S0140-6736(05)72401-6.
10
Pretransplant ursodeoxycholic acid therapy and liver transplantation in patients with primary biliary cirrhosis: win, win, win?
Liver Transpl Surg. 1999 Jul;5(4):334-7. doi: 10.1002/lt.500050403.
引用本文的文献
1
Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment.
Dig Dis Sci. 2004 Aug;49(7-8):1190-5. doi: 10.1023/b:ddas.0000037811.48575.da.
2
Methylprednisolone administration in primary biliary cirrhosis increases cholic acid turnover, synthesis, and deoxycholate concentration in bile.
Dig Dis Sci. 1999 Dec;44(12):2478-83. doi: 10.1023/a:1026687022202.
3
Ursodeoxycholic acid therapy for primary biliary cirrhosis. A 10-year British single-centre population-based audit of efficacy and survival.
Postgrad Med J. 1998 Aug;74(874):482-5. doi: 10.1136/pgmj.74.874.482.
本文引用的文献
1
Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.
J Clin Invest. 1993 Jun;91(6):2653-64. doi: 10.1172/JCI116504.
2
Hepatoprotective properties of ursodeoxycholic acid.
Gastroenterology. 1993 Jun;104(6):1865-70. doi: 10.1016/0016-5085(93)90672-y.
3
Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosis.
Dig Dis Sci. 1993 May;38(5):896-902. doi: 10.1007/BF01295917.
4
Serum bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid therapy.
Hepatology. 1993 Apr;17(4):599-604. doi: 10.1002/hep.1840170412.
5
Molecular aspects of membrane stabilization by ursodeoxycholate [see comment].
Gastroenterology. 1993 Jun;104(6):1736-44. doi: 10.1016/0016-5085(93)90653-t.
6
The immunosuppressive effect of ursodeoxycholic acid: a comparative in vitro study on human peripheral blood mononuclear cells.
Hepatology. 1993 Jul;18(1):165-72.
7
Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of disease.
Dig Dis Sci. 1994 Jan;39(1):9-14. doi: 10.1007/BF02090053.
8
Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.
Gastroenterology. 1994 Jan;106(1):134-42. doi: 10.1016/s0016-5085(94)94899-2.
9
Combined treatment with ursodeoxycholic acid and prednisone in primary biliary cirrhosis.
Neth J Med. 1994 Mar;44(3):84-90.
10
The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis.
Hepatology. 1994 May;19(5):1149-56.
Zotero 插件